Clinical Trials Browser

Phase 3 × Completed × pomalidomide × Clear all

NCT03180736 2025-12-19

EMN14

Phase 3 Completed

304 enrolled 19 charts 1 FDA

Multiple Myeloma

NCT02990338 2025-01-17

ICARIA-MM

Phase 3 Completed

307 enrolled 32 charts 1 FDA

Multiple Myeloma

NCT01734928 2023-06-06

OPTIMISMM

Phase 3 Completed

559 enrolled 16 charts

Multiple Myeloma

NCT02726581 2023-03-27

CheckMate 602

Phase 3 Completed

170 enrolled 16 charts

Multiple Myeloma

NCT01712789 2022-01-10

STRATUS

Phase 3 Completed

682 enrolled 23 charts

Multiple Myeloma, Recurrence

NCT01324947 2019-11-19

Study to Evaluate the Safety and Efficacy of Pomalidomide Monotherapy in Subjects With Refractory or Relapsed Refractory Multiple Myeloma

Phase 3 Completed

74 enrolled 17 charts

Multiple Myeloma, Recurrence, Neoplasms, Plasma Cell

NCT01178281 2019-07-17

RESUME

Phase 3 Completed

267 enrolled 19 charts

Primary Myelofibrosis

NCT01243944 2019-03-06

Study of Efficacy and Safety in Polycythemia Vera Subjects Who Are Resistant to or Intolerant of Hydroxyurea: JAK Inhibitor INC424 (INCB018424) Tablets Versus Best Available Care: (The RESPONSE Trial)

Phase 3 Completed

222 enrolled 21 charts

Polycythemia Vera

NCT01311687 2018-10-24

NIMBUS

Phase 3 Completed

455 enrolled 38 charts

Multiple Myeloma, Recurrence, Neoplasms, Plasma Cell